Page 1

ENDOCRINE & METABOLIC PSI is a leading, full-service CRO specializing in on-time delivery of clinical studies. PSI positions itself as a ‘no-nonsense’ CRO capable of saving our sponsors millions of development dollars by consistently meeting clinical trial timelines. PSI’s global reach supports the operations of clinical trials across multiple countries and continents. PSI’s dedicated Feasibility Department, comprised of medical specialists, laboratory experts, imaging specialists, logisticians and regulatory experts, has conducted feasibility across a wide range of endocrine and metabolic disease indications. When we apply this process to your trial and combine it with our knowledge of the nuances and complexities associated with endocrine and metabolic disease studies, we are able to provide recommendations for the best choice of sites, geography and realistic timelines for your study. 250+ of our staff members hold Medical Degrees and many possess board-certifications in specialties that include endocrinology, internal medicine and pediatrics. We have all the means to ensure a team of experts will run your study.

PSI has the following Phase II-IV experience in Endocrine & Metabolic Diseases: Diabetes Mellitus in CAPD & APD Patients Diabetes Mellitus Type II (adult and pediatric) Diabetes Mellitus Type I Hunter Syndrome (pediatric) Hypothyroidism Osteoporosis (adult and pediatric) Sanfilippo Syndrome (pediatric)

The PSI monitoring team has always set the standard for excellence in performance on the study. Clinical Trial Manager, USA

For more information about PSI, please visit our website WWW.PSI-CRO.COM or reach us at CONTACT@PSI-CRO.COM

PSI CRO AG Corporate Headquarters Baarerstrasse 113a 6300 Zug, Switzerland Tel: +41 41 228 10 00

Global Office Locations North America Ft. Washington, PA Burlingame, CA San Francisco, CA

Latin America Buenos Aires, Argentina

Europe Oxford, UK Munich, Germany Neusiedl am See, Austria Minsk, Belarus Sofia, Bulgaria Prague, Czech Republic Tallinn, Estonia Budapest, Hungary Milan, Italy Warsaw, Poland Bucharest, Romania Belgrade, Serbia Kiev, Ukraine Russian Federation: St. Petersburg, Moscow, Novosibirsk

Operational Presence by Region North America / Europe / Latin America Asia-Pacific / South Africa


Us new endocrinemetabolic